BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 23305046)

  • 1. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
    Nakamura T; Inagaki H; Seto M; Nakamura S
    J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
    Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
    J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
    Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
    Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
    Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
    World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.
    Raderer M; Streubel B; Wöhrer S; Häfner M; Chott A
    Gut; 2006 May; 55(5):616-8. PubMed ID: 16299027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T; Thiede C; Morgner A; Dempfle A; Günther A; Liu H; Ye H; Du MQ; Kim TD; Bayerdörffer E; Stolte M; Neubauer A
    J Clin Oncol; 2005 Nov; 23(31):8018-24. PubMed ID: 16204012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
    Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
    Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
    Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
    Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
    Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.